“…Over all CAGI editions, the plurality of challenges have been on the interpretation of isolated missense variants, and CAGI5 continues that trend. There are assessment, data provider, and participant papers for the prediction of the destabilizing effect of missense mutations in a cancer‐relevant protein (Frataxin, with biophysical measurements of protein stability; Petrosino et al, ; Savojardo, Petrosino et al, ; Strokach, Corbi‐Verge, & Kim, ); on the effect of missense changes in a human calmodulin, assayed using a high‐throughput yeast complementation assay (Zhang et al, ); the effect of missense mutations related to schizophrenia in human Pericentriolar Material 1 ( PCM1 ), using a zebrafish development model (Miller, Wang, & Bromberg, ; Monzon et al, ); the effect of missense mutations in two cancer‐related proteins, PTEN and TPMT , on intracellular protein levels, measured in a high‐throughput assay (Pejaver et al, ); and the effect of missense changes in a monogenic disease related protein, acid alpha‐glucosidase ( GAA ), with measurements of total intracellular enzyme activity (Adhikari, ). Three participant papers describe results on all the missense challenges (Garg & Pal, ; Katsonis & Lichtarge, ; Savojardo, Babbi et al, ).…”